Cargando…
IL-17 inhibitor-associated inflammatory bowel disease: A study based on literature and database analysis
Objective: Few real-world studies have shown clear association between interleukin (IL)-17 inhibitors and inflammatory bowel disease (IBD) onset. This study investigated the reporting prevalence and evaluated the clinical features and management of IL-17 inhibitor-related IBD events. Methods: We use...
Autores principales: | Deng, Zhenzhen, Wang, Shengfeng, Wu, Cuifang, Wang, Chunjiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10076642/ https://www.ncbi.nlm.nih.gov/pubmed/37033665 http://dx.doi.org/10.3389/fphar.2023.1124628 |
Ejemplares similares
-
Rhabdomyolysis associated with newer-generation anti-seizure medications (ASMs): a real-world retrospective and pharmacovigilance study
por: Deng, Zhenzhen, et al.
Publicado: (2023) -
Literature review of the clinical characteristics of metformin-induced hepatotoxicity
por: Wang, Chunjiang, et al.
Publicado: (2022) -
Emerging Biological Functions of IL-17A: A New Target in Chronic Obstructive Pulmonary Disease?
por: Liu, Meiling, et al.
Publicado: (2021) -
Natural Anti-Inflammatory Compounds as Drug Candidates for Inflammatory Bowel Disease
por: Duan, Linshan, et al.
Publicado: (2021) -
Precision Medicine in Inflammatory Bowel Diseases
por: Marafini, Irene, et al.
Publicado: (2021)